Magdałene Władysiuk

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

Brian Godman, Andrew Hill, Steven Simoens et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2021 · 73 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +17

Proposal for a regulation on health technology assessment in Europe – opinions of policy makers, payers and academics from the field of HTA

Patricia Vella Bonanno, Anna Bucsics, Steven Simoens et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2019 · 46 citations · Full text

Social Sciences, Health Law, Health Policy +13

Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Brian Godman, Andrew Hill, Steven Simoens et al. · Generics and Biosimilars Initiative Journal · 2019 · 45 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +17

The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

Brian Godman, Mainul Haque, Trudy Leong et al. · Frontiers in Public Health · 2021 · 37 citations · Full text

Medicine, Pharmacoeconomics, Pharmacology +13

Utilisation Trend of Long‐Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications

Brian Godman, Magdałene Władysiuk, Stuart McTaggart et al. · BioMed Research International · 2021 · 14 citations · Full text

Medicine, Pharmacoeconomics, Pharmacology +14